MLICM
DGX icon

Metropolitan Life Insurance Company (MetLife)’s Quest Diagnostics DGX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,476
Closed -$596K – 589
2024
Q1 		$596K Sell
4,476
-100
-2% -$13K 0.03% 448
2023
Q4 		$631K Sell
4,576
-67
-1% -$8.81K 0.03% 420
2023
Q3 		$566K Sell
4,643
-237
-5% -$31.6K 0.03% 420
2023
Q2 		$686K Sell
4,880
-84
-2% -$11.6K 0.03% 394
2023
Q1 		$702K Sell
4,964
-1,445
-23% -$207K 0.04% 392
2022
Q4 		$1M Sell
6,409
-419
-6% -$60.2K 0.04% 367
2022
Q3 		$838K Sell
6,828
-126
-2% -$16.6K 0.04% 388
2022
Q2 		$925K Sell
6,954
-275
-4% -$37.5K 0.04% 385
2022
Q1 		$989K Sell
7,229
-6,658
-48% -$928K 0.04% 420
2021
Q4 		$2.4M Sell
13,887
-477
-3% -$72.6K 0.03% 436
2021
Q3 		$2.09M Sell
14,364
-1,516
-10% -$222K 0.03% 479
2021
Q2 		$2.1M Sell
15,880
-606
-4% -$79.3K 0.03% 498
2021
Q1 		$2.12M Sell
16,486
-958
-5% -$118K 0.03% 490
2020
Q4 		$2.08M Sell
17,444
-875
-5% -$107K 0.03% 463
2020
Q3 		$2.1M Sell
18,319
-740
-4% -$87.4K 0.04% 402
2020
Q2 		$2.17M Sell
19,059
-1,273
-6% -$135K 0.04% 374
2020
Q1 		$1.63M Sell
20,332
-111
-0.5% -$11.5K 0.03% 461
2019
Q4 		$2.18M Buy
20,443
+51
+0.3% +$5.32K 0.03% 498
2019
Q3 		$2.18M Buy
20,392
+68
+0.3% +$6.98K 0.04% 461
2019
Q2 		$2.07M Buy
20,324
+1,291
+7% +$124K 0.03% 510
2019
Q1 		$1.71M Sell
19,033
-727
-4% -$63K 0.03% 568
2018
Q4 		$1.65M Sell
19,760
-149
-0.7% -$14K 0.03% 536
2018
Q3 		$2.15M Sell
19,909
-640
-3% -$70.2K 0.04% 479
2018
Q2 		$2.26M Sell
20,549
-622
-3% -$64.8K 0.04% 453
2018
Q1 		$2.12M Buy
21,171
+44
+0.2% +$4.51K 0.03% 496
2017
Q4 		$2.08M Sell
21,127
-43,390
-67% -$4.11M 0.03% 521
2017
Q3 		$6.04M Sell
64,517
-1,362
-2% -$145K 0.04% 471
2017
Q2 		$7.32M Sell
65,879
-2,231
-3% -$236K 0.05% 358
2017
Q1 		$6.69M Sell
68,110
-1,570
-2% -$150K 0.05% 405
2016
Q4 		$6.4M Sell
69,680
-2,373
-3% -$205K 0.05% 426
2016
Q3 		$6.1M Sell
72,053
-1,704
-2% -$143K 0.04% 422
2016
Q2 		$6M Sell
73,757
-1,460
-2% -$111K 0.04% 427
2016
Q1 		$5.37M Sell
75,217
-1,888
-2% -$127K 0.04% 474
2015
Q4 		$5.49M Sell
77,105
-1,480
-2% -$99.5K 0.04% 455
2015
Q3 		$4.83M Sell
78,585
-1,468
-2% -$103K 0.03% 525
2015
Q2 		$5.8M Sell
80,053
-1,043
-1% -$77K 0.04% 459
2015
Q1 		$6.23M Sell
81,096
-1,172
-1% -$83.9K 0.05% 424
2014
Q4 		$5.52M Sell
82,268
-553
-0.7% -$34.9K 0.04% 492
2014
Q3 		$5.03M Sell
82,821
-1,235
-1% -$76.1K 0.04% 504
2014
Q2 		$4.93M Sell
84,056
-4,425
-5% -$259K 0.03% 550
2014
Q1 		$5.13M Sell
88,481
-2,011
-2% -$108K 0.04% 521
2013
Q4 		$4.84M Sell
90,492
-6,131
-6% -$364K 0.03% 529
2013
Q3 		$5.97M Sell
96,623
-4,246
-4% -$254K 0.05% 420
2013
Q2 		$6.12M Buy
+100,869
New +$6.01M 0.05% 392

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s DGX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Quest Diagnostics (DGX) in Q2 2024, closing a stake of 4,476 shares — an estimated $596K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DGX in Q2 2013 and held it in 44 quarters. The position peaked at $7.32M in Q2 2017. 838 funds tracked by Wall St. Rank hold DGX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Quest Diagnostics position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,476 Quest Diagnostics shares in Q2 2024, an estimated $596K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Quest Diagnostics in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Quest Diagnostics position peaked at $7.32M in Q2 2017.
  • 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.